Ignite Creation Date:
2025-12-24 @ 6:30 PM
Ignite Modification Date:
2025-12-28 @ 10:20 AM
Study NCT ID:
NCT04396457
Status:
UNKNOWN
Last Update Posted:
2023-03-23
First Post:
2020-01-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901
Sponsor:
National Hospital Organization Nagoya Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NMC-CJLSG1901
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None